Holen Sie sich die Stockscreener-App
2.745
3.28%
0.045
Aethlon Medical Inc Aktie (AEMD) Neueste Nachrichten
Aethlon (AEMD) Quarterly Results: The EPS Result Is Below Expectation in the Available Record; Price Reaction: The Stock Ends Down 3.81%Earnings Risk Report - Vinanet
Aethlon Medical at emerging growth conference: early cancer signal builds By Investing.com - Investing.com South Africa
Aethlon Medical at emerging growth conference: early cancer signal builds - Investing.com
Aethlon (AEMD) Watch: Trades in a Narrow Directional Range at $2.89; Immediate View: the Price Remains Bounded by the Supplied Support and Resistance on the DayAAII Bullish - Vinanet
Maxim Group Maintains Aethlon Medical(AEMD.US) With Hold Rating - Moomoo
H.C. Wainwright reiterates Aethlon Medical stock rating at Neutral By Investing.com - Investing.com South Africa
Aethlon (AEMD) Quarter in Review: EPS Comes in Below Forecast in the Available Record; Post-Report Move: Shares Finish 4.71% Down in the Latest ReadingAnnual Earnings Summary - Vinanet
Aethlon Medical (AEMD) Falls 3.7% to $2.83 as Support Level LoomsCollar Trade - Vinanet
AEMD Q2 2026 Earnings: Wider-than-Expected Loss of -$4.02 Per Share Highlights Clinical-Stage Challenges - Vinanet
Aethlon Medical, Inc. Q1 2027 Earnings Call Summary - Yahoo Finance
Aethlon Medical Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Earnings call transcript: Aethlon Medical posts Q1 2026 loss miss as trial advances - Investing.com Nigeria
Aethlon Medical (AEMD) trims quarterly loss and raises $4M in new funding - Stock Titan
Aethlon Medical Q1 Results: EPS misses estimate, losses widen - scanx.trade
Aethlon Medical Advances Hemopurifier Trials and Bolsters Liquidity - TipRanks
AETHLON MEDICAL ($AEMD) Releases Q1 2027 Earnings - Quiver Quantitative
Aethlon Medical Reports Q1 Fiscal 2027 Results and Progress on Hemopurifier® Program - marketscreener.com
Aethlon Medical (AEMD) investors disclose 55,556-share warrant position, 2.3% stake - Stock Titan
Q3 2026 Aethlon Medical Inc Earnings Call Transcript - GuruFocus
Q1 2026 Aethlon Medical Inc Earnings Call Transcript - GuruFocus
Asset turnover of Aethlon Medical, Inc. – LS:A42HQZ - TradingView
Inventory turnover of Aethlon Medical, Inc. – LS:A42HQZ - TradingView
Total assets of Aethlon Medical, Inc. – LS:A42HQZ - TradingView
Diluted shares outstanding of Aethlon Medical, Inc. – LS:A42HQZ - TradingView
Net income before discontinued operations of Aethlon Medical, Inc. – LS:A42HQZ - TradingView
AEMD Q2 2026 Earnings: Narrower Loss Beats Estimates, Shares Rise 3.75%High Estimate Range - Vinanet
AEMD Q1'26 Earnings: EPS estimate is (3.92) USD - TradingView
Aethlon Medical Inc expected to post a loss of 78 cents a shareEarnings Preview - TradingView
Aethlon Medical (AEMD.US) will release its earnings report after market close on August 13. - Moomoo
Stock splits calendar for: - Yahoo Finance UK
Aethlon Medical schedules Aug. 13 call on quarter ended June 30 - Stock Titan
Stock Splits Calendar for: - Yahoo! Finance Canada
Market Movers | Winners: AEMD, HYFM, FUSE | Losers: GYGY, CALC, MIRA - Trefis
Calendrier des fractionnements d'actions pour: - Yahoo Finance France
Aethlon Medical To Carry Out 1-for-5 Reverse Stock Split On August 4th, 2026 - Moomoo
AEMD Q2 2026 Earnings: Narrower-Than-Expected Loss Boosts Shares 17%Earnings Acceleration Picks - Vinanet
Aethlon Medical Announces Reverse Stock Split Implementation - TipRanks
Aethlon Medical, Inc. Announces 1-for-5 Reverse Stock Split Effective July 30, 2026 - Minichart
Aethlon Medical (AEMD) Holds Steady Near Support as Trading Volume Remains SubduedBlue Chip Entry Points - Vinanet
Aethlon Medical Inc (AEMD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
TradingKey - TradingKey
Aethlon Medical, Inc. Revenue Breakdown – NASDAQ:AEMD - TradingView
AEMD Q2 2026 Earnings: Narrower-Than-Expected Loss Per ShareAnnual Earnings Summary - Vinanet
Aethlon Medical (AEMD) Dips 3.4% to $0.63 as Small-Cap Biotech Faces Persistent Selling PressureIntraday Profile - dars.gov.et
AETHLON MEDICAL INC (AEMD) Stock Chart - ChartMill
Aethlon Medical (AEMD) Slips 1.5% as Stock Tests Key Support at $0.63Time Weighted Price - Vinanet
Aethlon Medical at emerging growth conference: trial data and cash boost - Investing.com
AEMD: Hemopurifier shows early promise in oncology trials, with strong platform and financial position - TradingView
Aethlon Medical Reports Encouraging Hemopurifier Trial Results - t.co
Aethlon Medical (AEMD) Gains 2.39% as Stock Approaches $0.70 Resistance LevelSupport Level Bounce - dars.gov.et
Aethlon Medical reports second cohort results from cancer study - Investing.com UK
Aethlon Medical (AEMD) Slides 5.4% as Pressure Mounts Near Key Support LevelEarnings Beat Stocks - dars.gov.et
Aethlon Medical advances Hemopurifier oncology study to third cohort - grafa.com
Aethlon Medical reports second cohort results from cancer study By Investing.com - Investing.com South Africa
Experimental cancer filter shows repeat immune and tumor-signal shifts in small Australian study - Stock Titan
Aethlon Medical Inc. (AEMD) Q2 2026 Earnings: Narrower Loss Exceeds ExpectationsPretax Income Report - DonanımHaber
Aethlon Medical Announces $4 Million At-the-Market Offering to Advance Cancer and Infectious Disease Therapies - Minichart
Aethlon Medical Announces July 2026 Financing Offering - TipRanks
Aethlon Medical (NASDAQ: AEMD) prices $4M follow-on at-the-market deal - Stock Titan
0.32%
0.75%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):